Accessibility Menu
Qiagen Stock Quote

Qiagen (NYSE: QGEN)

$48.60
(0.1%)
+0.05
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$48.6
Daily Change
(0.1%) +$0.05
Day's Range
$48.34 - $48.89
Previous Close
$48.6
Open
$48.49
Beta
0.61
Volume
682,059
Average Volume
1,287,945
Market Cap
10.5B
Market Cap / Employee
$48.55M
52wk Range
$37.63 - $51.88
Revenue
-
Gross Margin
0.63%
Dividend Yield
0.51%
EPS
$1.71
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Qiagen Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
QGEN+15.88%-3.39%-0.69%+2,482%
S&P+14.5%+93.32%+14.09%+899%

Qiagen Company Info

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$533.54M7.5%
Gross Profit$332.47M5.5%
Gross Margin62.31%-1.2%
Market Cap$10.41B13.1%
Market Cap / Employee$1.81M0.0%
Employees5.8K-3.4%
Net Income$96.25M152.5%
EBITDA$185.45M5.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$733.82M37.5%
Accounts Receivable$385.76M4.5%
Inventory292.6-9.1%

Liabilities

Q2 2025YOY Change
Long Term Debt$884.85M-2.6%
Short Term Debt$559.19M13.5%

Ratios

Q2 2025YOY Change
Return On Assets6.55%5.3%
Return On Invested Capital7.35%0.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$121.25M-5.6%
Operating Free Cash Flow$161.44M-3.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings112.89123.2996.1928.13-78.52%
Price to Book2.872.772.433.0519.49%
Price to Sales5.195.054.415.149.33%
Price to Tangible Book Value17.0714.2810.3515.566.69%
Price to Free Cash Flow TTM22.0319.7217.4821.03-4.63%
Enterprise Value to EBITDA59.3554.4454.5059.198.26%
Free Cash Flow Yield4.5%5.1%5.7%4.8%4.86%
Return on Equity2.6%2.3%2.7%10.8%422.41%
Total Debt$1.92B$1.51B$1.41B$1.44B3.03%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.